Phase 4 Hyperglycaemia Clinical Trials
6 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–6 of 6 trials
Recruiting
Phase 4
Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)
Overweight and ObesityHyperglycaemia (Diabetic)Type 2 Diabetes Patients
The First Affiliated Hospital of Xiamen University164 enrolled1 locationNCT03087032
Recruiting
Phase 4
Insulin Therapy for Postreperfusion Hyperglycemia
Liver TransplantationHyperglycaemia (Diabetic)
Seoul National University Hospital20 enrolled1 locationNCT03152890
Terminated
Phase 4
A Clinical Trial of Insulin Therapy for Dexamethasone Induced Hyperglycaemia amongst Diabetes Patients with COVID-19
Steroid induced hyperglycaemiaCOVID-19
Prof NW Cheung160 enrolled1 locationACTRN12621001340820
Not Yet Recruiting
Phase 4
The role of SGLT-2 inhibitors (Empagliflozin) in treating steroid induced hyperglycaemia in the management of glucocorticoid induced hypoerglycaemia in adults with and without diabetes.
Steroid induced hyperglycaemia
Endocrinology Department, Gosford Hospital30 enrolled2 locationsACTRN12620000745943
Completed
Phase 4
Treatment of steroid-induced diabetes in hospitalized patients
Prednisolone-induced hyperglycaemia
Dr Morton Burt50 enrolled1 locationACTRN12612000817842
Completed
Phase 4
High blood sugar levels and insulin treatment in preterm babies. The HINT trial.
Neonatal Hyperglycaemia
Dr Jane Alsweiler88 enrolled1 locationACTRN12606000270516